Rhenman & Partners Asset Management AB »

Revance Therapeutics shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.1M 123k 25.31
2023-06-30 $3.1M 123k 25.31
2023-03-31 $7.2M 230k 31.13
2022-12-31 $8.1M 438k 18.46
2022-09-30 $8.7M 388k 22.31
2022-06-30 $6.2M 450k 13.82
2022-03-31 $3.9M 198k 19.50
2021-09-30 $8.9M 320k 27.86
2021-06-30 $8.0M 270k 29.64
2021-03-31 $6.1M 220k 27.95
2020-12-31 $6.2M 220k 28.34
2020-09-30 $5.5M 220k 25.14
2020-06-30 $5.4M 220k 24.42
2020-03-31 $3.3M 220k 14.80
2019-12-31 $4.1M 250k 16.23
2019-09-30 $2.3M 174k 13.00
2019-06-30 $2.5M 193k 12.97
2019-03-31 $3.0M 193k 15.76
2018-12-31 $3.9M 193k 20.13
2018-09-30 $5.0M 203k 24.85
2018-06-30 $5.6M 203k 27.45
2018-03-31 $6.3M 203k 30.80
2017-12-31 $6.5M 183k 35.75
2017-09-30 $6.8M 246k 27.55
2017-06-30 $5.8M 220k 26.40
2017-03-31 $4.4M 210k 20.80
2016-12-31 $4.3M 210k 20.70
2016-09-30 $3.4M 210k 16.21
2016-06-30 $3.0M 220k 13.60
2016-03-31 $3.0M 170k 17.46
2015-12-31 $5.9M 173k 34.16
2015-09-30 $4.4M 148k 29.76
2015-06-30 $5.5M 172k 31.98
2015-03-31 $4.9M 236k 20.73
2014-12-31 $2.1M 127k 16.94
2014-09-30 $2.0M 105k 19.33
2014-06-30 $2.8M 82k 34.00
2014-03-31 $1.5M 49k 31.51